Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Cyclin-Dependent Kinase Inhibitor 3 (CDKN3) Peptide

CDKN3 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN974789

Quick Overview for Cyclin-Dependent Kinase Inhibitor 3 (CDKN3) Peptide (ABIN974789)

Target

CDKN3 (Cyclin-Dependent Kinase Inhibitor 3 (CDKN3))

Origin

Human

Source

  • 2
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Characteristics

    This is a synthetic peptide designed for use in combination with anti-CDKN3 antibody (Catalog #: ARP53629_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    CDKN3 (Cyclin-Dependent Kinase Inhibitor 3 (CDKN3))

    Background

    CDKN3 belongs to the dual specificity protein phosphatase family. It was identified as a cyclin-dependent kinase inhibitor, and has been shown to interact with, and dephosphorylate CDK2 kinase, thus prevent the activation of CDK2 kinase. This gene was reported to be deleted, mutated, or overexpressed in several kinds of cancers. The protein encoded by this gene belongs to the dual specificity protein phosphatase family. It was identified as a cyclin-dependent kinase inhibitor, and has been shown to interact with, and dephosphorylate CDK2 kinase, thus prevent the activation of CDK2 kinase. This gene was reported to be deleted, mutated, or overexpressed in several kinds of cancers. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

    Alias Symbols: CDI1, CIP2, FLJ25787, KAP, KAP1, MGC70625

    Protein Interaction Partner: CDC25A,CDK1,CDK2,CDK3,CDKN3,CEBPA,MS4A3,CDK1,CDK2,MS4A3

    Protein Size: 212

    Molecular Weight

    23 kDa

    Gene ID

    1033

    NCBI Accession

    NM_005192, NP_005183

    UniProt

    Q16667
You are here:
Chat with us!